Jonathan Symonds

Jonathan Richard Symonds is the founder of Felix Pharmaceuticals Pvt Ltd., founded in 2015.
Mr. Symonds is also the founder of Oxford University Centre for Business Taxation.
Current positions include Non-Executive Chairman at GSK Plc since 2019, Non-Executive Director at Genomics England Ltd. since 2019, Member of the Governors Board at Harrow School, Member of The Institute of Chartered Accountants in England & Wales, and Member of the European Round Table For Industry.
Former positions include Deputy Group Chairman at HSBC Holdings Plc from 2018 to 2020, Chairman at HSBC Bank Plc from 2014 to 2018, Chairman at Innocoll, Inc., Chairman-Supervisory Board at Innocoll AG, Chairman at The 100 Group, Chairman-Supervisory Board at Innocoll Biotherapeutics Holdings Ltd. from 2014 to 2017, Managing Director at The Goldman Sachs Group, Inc. from 2007 to 2009, Non-Executive Director at Diageo Plc from 2004 to 2007, Independent Director at Proteus Digital Health, Inc. from 2014 to 2015, Non-Executive Director at QinetiQ Group plc, Director-Finance at Zeneca Group Plc, Director at Accounting Standards Board, Independent Non-Executive Director at Rubius Therapeutics, Inc. from 2018 to 2023, Director at Berg LLC from 2016 to 2017, Chief Financial Officer at AstraZeneca PLC from 1997 to 2007, Chief Financial Officer at Novartis AG from 2012 to 2014, Partner at KPMG LLP (Canada) from 1992 to 1997, and Head-Corporate Finance & Strategy at Mesoblast Ltd. Education includes an undergraduate degree from the University of Hertfordshire, conferred in 1980.